Intraosseous Infusion of Unrelated Cord Blood Grafts
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
SCRI Tissue Testing Registry
- Status
- TERMINATED
- Phase
- N/A
NOV-002 in Myelodysplastic Syndrome (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
- Status
- UNKNOWN
- Phase
- PHASE2
Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study of Iron Overload in Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- N/A
Combined Haploidentical-Cord Blood Transplantation for Adults and Children
- Status
- COMPLETED
- Phase
- NA
Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Collection of Tissue Samples for Cancer Research
- Status
- RECRUITING
- Phase
- N/A
5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)
- Status
- COMPLETED
- Phase
- PHASE2
PR1 Vaccination in Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
- Status
- UNKNOWN
- Phase
- PHASE2